Trupanion, Inc. (NASDAQ:TRUP – Get Free Report)’s stock price reached a new 52-week low during trading on Thursday . The stock traded as low as $24.44 and last traded at $24.3250, with a volume of 93890 shares trading hands. The stock had previously closed at $25.68.
Wall Street Analyst Weigh In
TRUP has been the subject of several recent research reports. Piper Sandler lowered their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Weiss Ratings lowered shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 4th. Wall Street Zen cut shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Finally, Cantor Fitzgerald cut their price target on Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a report on Wednesday, January 14th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Trupanion currently has an average rating of “Hold” and a consensus target price of $45.50.
Check Out Our Latest Stock Analysis on TRUP
Trupanion Trading Down 4.1%
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). The company had revenue of $376.85 million during the quarter, compared to analyst estimates of $375.89 million. Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The company’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.04 EPS. As a group, sell-side analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.
Insider Activity
In related news, COO John R. Gallagher sold 5,283 shares of the stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $26.52, for a total value of $140,105.16. Following the completion of the transaction, the chief operating officer owned 32,387 shares of the company’s stock, valued at $858,903.24. This represents a 14.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Margaret Tooth sold 9,605 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $37.88, for a total transaction of $363,837.40. Following the transaction, the chief executive officer owned 150,294 shares of the company’s stock, valued at approximately $5,693,136.72. This represents a 6.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 31,107 shares of company stock valued at $949,347 in the last quarter. 5.42% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Trupanion
Hedge funds and other institutional investors have recently modified their holdings of the stock. Federated Hermes Inc. bought a new stake in shares of Trupanion in the 3rd quarter worth about $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Trupanion in the third quarter valued at about $39,000. Kemnay Advisory Services Inc. bought a new stake in Trupanion during the fourth quarter worth about $64,000. Kelleher Financial Advisors bought a new stake in Trupanion during the third quarter worth about $74,000. Finally, PNC Financial Services Group Inc. increased its holdings in shares of Trupanion by 21.7% during the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock worth $116,000 after buying an additional 478 shares in the last quarter.
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
